119 related articles for article (PubMed ID: 36812496)
1. MALAT-1 regulates the AML progression by promoting the m6A modification of ZEB1.
Jin J; Fu L; Hong P; Feng W
Acta Biochim Pol; 2023 Feb; 70(1):37-43. PubMed ID: 36812496
[TBL] [Abstract][Full Text] [Related]
2. A novel feedback loop between high MALAT-1 and low miR-200c-3p promotes cell migration and invasion in pancreatic ductal adenocarcinoma and is predictive of poor prognosis.
Zhuo M; Yuan C; Han T; Cui J; Jiao F; Wang L
BMC Cancer; 2018 Oct; 18(1):1032. PubMed ID: 30352575
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of long non-coding RNA MALAT-1 confers poor prognosis and influences cell proliferation and apoptosis in acute monocytic leukemia.
Huang JL; Liu W; Tian LH; Chai TT; Liu Y; Zhang F; Fu HY; Zhou HR; Shen JZ
Oncol Rep; 2017 Sep; 38(3):1353-1362. PubMed ID: 28713913
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-1306-5p Regulates the METTL14-Guided m6A Methylation to Repress Acute Myeloid Leukemia.
Li J; Wu Y; Wang M; Chen X; Li Z; Bai X; Wu H
Comput Math Methods Med; 2022; 2022():5787808. PubMed ID: 36118827
[TBL] [Abstract][Full Text] [Related]
5. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
6. Silencing of long noncoding RNA TUG1 inhibits viability and promotes apoptosis of acute myeloid leukemia cells by targeting microRNA-221-3p/KIT axis.
Zhang X; Yang L; Xu G
Clin Hemorheol Microcirc; 2020; 76(3):425-437. PubMed ID: 32804119
[TBL] [Abstract][Full Text] [Related]
7. Biological function and mechanism of MALAT-1 in renal cell carcinoma proliferation and apoptosis: role of the MALAT-1-Livin protein interaction.
Chen S; Ma P; Zhao Y; Li B; Jiang S; Xiong H; Wang Z; Wang H; Jin X; Liu C
J Physiol Sci; 2017 Sep; 67(5):577-585. PubMed ID: 27655020
[TBL] [Abstract][Full Text] [Related]
8. MALAT1 knockdown inhibits proliferation and enhances cytarabine chemosensitivity by upregulating miR-96 in acute myeloid leukemia cells.
Hu N; Chen L; Wang C; Zhao H
Biomed Pharmacother; 2019 Apr; 112():108720. PubMed ID: 30970520
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of long non-coding RNA MALAT1 elevates microRNA-429 to suppress the progression of hypopharyngeal squamous cell carcinoma by reducing ZEB1.
Liu X; Zhao W; Wang X
Life Sci; 2020 Dec; 262():118480. PubMed ID: 32980391
[TBL] [Abstract][Full Text] [Related]
10. LncRNA UCA1 Promotes the Progression of AML by Upregulating the Expression of CXCR4 and CYP1B1 by Affecting the Stability of METTL14.
Li J; Li Z; Bai X; Chen X; Wang M; Wu Y; Wu H
J Oncol; 2022; 2022():2756986. PubMed ID: 35178087
[TBL] [Abstract][Full Text] [Related]
11. LncRNA ZEB1-AS1 regulates hepatocellular carcinoma progression by targeting miR-23c.
Xue S; Lu F; Sun C; Zhao J; Zhen H; Li X
World J Surg Oncol; 2021 Apr; 19(1):121. PubMed ID: 33865414
[TBL] [Abstract][Full Text] [Related]
12. MAPKAPK5-AS1 drives the progression of hepatocellular carcinoma via regulating miR-429/ZEB1 axis.
Peng Z; Ouyang X; Wang Y; Fan Q
BMC Mol Cell Biol; 2022 Apr; 23(1):21. PubMed ID: 35468721
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA SNHG1 regulates zinc finger E-box binding homeobox 1 expression by interacting with TAp63 and promotes cell metastasis and invasion in Lung squamous cell carcinoma.
Zhang HY; Yang W; Zheng FS; Wang YB; Lu JB
Biomed Pharmacother; 2017 Jun; 90():650-658. PubMed ID: 28415044
[TBL] [Abstract][Full Text] [Related]
14. LncRNA NEAT1 Promotes the Malignant Progression of Colorectal Cancer by Targeting ZEB1 via miR-448.
Wu H; Dong D; Wang J; Yin S; Gong Y; Yang C; Bai Y; Wang J; Du Y
Technol Cancer Res Treat; 2022; 21():15330338221085348. PubMed ID: 35695254
[No Abstract] [Full Text] [Related]
15. MiR-326 mediates malignant biological behaviors of lung adenocarcinoma by targeting ZEB1.
Liu M; Wu H; Liu Y; Tan Y; Wang S; Xie S; Xiang R; Liang J; Zhang R; Xu C; He J; Li Q
Sci Prog; 2021; 104(2):368504211009379. PubMed ID: 33913391
[TBL] [Abstract][Full Text] [Related]
16. LncRNA KCNQ1OT1 controls cell proliferation, differentiation and apoptosis by sponging miR-326 to regulate c-Myc expression in acute myeloid leukemia.
Cheng P; Lu P; Guan J; Zhou Y; Zou L; Yi X; Cheng H
Neoplasma; 2020 Mar; 67(2):238-248. PubMed ID: 31390869
[TBL] [Abstract][Full Text] [Related]
17. LINC00987 knockdown inhibits the progression of acute myeloid leukemia by suppressing IGF2BP2-mediated PA2G4 expression.
Liu C; Ma Y; Wang R; Su G
Anticancer Drugs; 2022 Jan; 33(1):e207-e217. PubMed ID: 34407052
[TBL] [Abstract][Full Text] [Related]
18. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
[TBL] [Abstract][Full Text] [Related]
19. Silencing long non-coding RNA XIST suppresses drug resistance in acute myeloid leukemia through down-regulation of MYC by elevating microRNA-29a expression.
Wang C; Li L; Li M; Wang W; Liu Y; Wang S
Mol Med; 2020 Nov; 26(1):114. PubMed ID: 33228517
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA MALAT1 modulate cell migration, proliferation and apoptosis by sponging microRNA-146a to regulate CXCR4 expression in acute myeloid leukemia.
Sheng XF; Hong LL; Li H; Huang FY; Wen Q; Zhuang HF
Hematology; 2021 Dec; 26(1):43-52. PubMed ID: 33382018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
